Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
RIDA®GENE 2.0
New: RIDA®GENE Parainfluenza
Human parainfluenza viruses (HPIV) can cause both upper respiratory infections and lower respiratory infections.
Reliable detection of novel influenza A variants with R-Biopharm RIDA®GENE test systems
Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]
And again: Cold – Cough – Fever
Hospital acquired infections
Parasitology
Influenza season 2015 dominated by new influenza A variant (H3N2)
The RIDA®GENE real-time PCR assays for the detection of Influenza (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) detect the currently circulating drift variant of influenza A (H3N2).
Helicobacter pylori & its resistance against clarithromycin – detect it simultaneously!
RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human [...]
Influenza: Well-armed for the 2017/2018 flu season
As temperatures grow colder, the risk of catching the flu virus rises as well. This year, Australia is experiencing the worst flu epidemic in 15 years. Are Europe and North America also facing [...]